novel treatments

Research in Review

New Therapy May Effectively Treat Rare B-Cell Malignancy

05/18/2017

JCP Editors

A new treatment for a rare B-cell malignancy provided an objective response rate of 41% in a clinical trial, published in Blood (published online May 10, 2017; doi:10.1182/blood-2016-12-758383). ----- Related...

A new...

05/18/2017

Journal of Clinical Pathways

Research in Review

PD-1 Expression in T Cells Aids Immunotherapy Strategies for NSCLC

05/12/2017

JCP Editors

Early activation of programmed cell death-1 (PD-1) in CD8 T-cells after immunotherapy treatment is crucial to antitumor response for patients with non-small cell lung cancer (NSCLC), according to research published...

Early...

05/12/2017

Journal of Clinical Pathways

Research in Review

Stereotactic Ablative Radiation Therapy Effective in Treating Kidney Cancer

05/08/2017

JCP Editors

Stereotactic ablative radiation therapy can achieve more than 90% control of renal cell carcinoma metastases, according to a study published in the International Journal of Radiation Oncology, Biology, and Physics...

...

05/08/2017

Journal of Clinical Pathways

Research in Review

PD-1 Expression in T-Cells Aids Immunotherapy Strategies for NSCLC

05/01/2017

JCP Editors

Early activation of programmed cell death-1 (PD-1) in CD8 T-cells after immunotherapy treatment is crucial to anti-tumor response for patients with non-small cell lung cancer (NSCLC), according to research published...

Early...

05/01/2017

Journal of Clinical Pathways

Research in Review

Neurofeedback Reduces Nerve Damage From Chemotherapy in Cancer Survivors

04/11/2017

JCP Editors

Chemotherapy-induced peripheral neuropathy (CIPN) may be significantly reduced by electroencephalogram (EEG) neurofeedback training, according to research published in Cancer (published online March 3, 2017;...

...

04/11/2017

Journal of Clinical Pathways

Research in Review

Novel Therapy Plus Gemcitabine Does Not Improve OS in Pancreatic Cancer

04/11/2017

JCP Editors

A new tyrosine kinase inhibitor (TKI) in combination with gemcitabine does not improve overall survival (OS) any more than gemcitabine alone for patients with advanced pancreatic cancer, according to research...

A new...

04/11/2017

Journal of Clinical Pathways

Research in Review

Combination Therapy Improves Efficacy of B-Cell Lymphoma Treatment

03/20/2017

JCP Editors

Combining two treatment strategies for the treatment of B-cell lymphoma may be more effective than either strategy alone, according to a study published in Cell Reports (February 28,...

...

03/20/2017

Journal of Clinical Pathways

Research in Review

International Guidelines Issued for Management of Sepsis, Septic Shock

03/15/2017

JCP Editors

The Surviving Sepsis Campaign, with the Society of Critical Care Management and the European Society of Intensive Care Medicine, published international guidelines for the management of sepsis and septic shock in...

The...

03/15/2017

Journal of Clinical Pathways

Research in Review

Neurofeedback Reduces Nerve Damage From Chemo in Cancer Survivors

03/13/2017

JCP Editors

...

03/13/2017

Journal of Clinical Pathways

Research in Review

Combination Therapy Improves Outcomes for Patients With CLL

03/10/2017

JCP Editors

The addition of a novel monoclonal antibody to ibrutinib significantly improves survival outcomes for patients with previously treated high-risk chronic lymphocytic leukemia (CLL), according to the results of a phase...

The...

03/10/2017

Journal of Clinical Pathways